findmyKOL
Clinical trialNCT03439670CompletedPhase 2Interventional

A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

SponsorReveraGen BioPharma, Inc.Enrollment121Duchenne Muscular Dystrophy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Royal Children'S Hospital

    Melbourne, Australia

  • Sydney Children'S Hospital

    Westmead, Australia

Belgium
  • Ghent University Hospital

    Ghent, Belgium

  • University Hospitals Leuven

    Leuven, Belgium

Canada
  • Alberta'S Children Hospital

    Calgary, Alberta, Canada

  • British Columbia Children'S Hospital

    Vancouver, British Columbia, Canada

  • Children'S Hospital of Eastern Ontario

    Ottawa, Ontario, Canada

  • Montreal Children'S Hospital

    Montreal, Quebec, Canada

Czechia
  • University Hospital Brno

    Brno, Czechia

  • Charles University

    Prague, Czechia

Greece
  • Agia Sofia Children'S Hospital

    Athens, Greece

Israel
  • Schneider Children'S Medical Center

    Petah Tikvah, Israel

Netherlands
  • Leiden University Medical Center

    Leiden, Netherlands

  • Radboud University

    Nijmegen, Netherlands

Spain
  • Sant Joan de Deu Hospital - Barcelona, Spain

    Barcelona, Spain

  • Hospital Universitario Y Politécnico la Fe

    Valencia, Spain

Sweden
  • Queen Silvia Children'S Hospital

    Gothenburg, Sweden

United Kingdom
  • Birmingham Heartlands Hospital

    Birmingham, United Kingdom

  • Royal Hospital for Children

    Glasgow, United Kingdom

  • Leeds Teaching Hospital Trust

    Leeds, United Kingdom

  • Alder Hey Children'S Nhs Foundation Trust

    Liverpool, United Kingdom

  • Great Ormond Street Hospital

    London, United Kingdom

  • Newcastle Upon Tyne Hospitals Nhs Foundation Trust

    Newcastle upon Tyne, United Kingdom

United States
  • University of California Davis

    Davis, California, United States

  • University of California Los Angeles

    Los Angeles, California, United States

  • Children'S Hospital Colorado

    Aurora, Colorado, United States

  • Nemours Children'S Hospital

    Orlando, Florida, United States

  • Ann & Robert H. Lurie Children'S Hospital

    Chicago, Illinois, United States

  • Gillette Children'S Speciality Health Care

    Saint Paul, Minnesota, United States

  • Duke Children'S Hospital

    Durham, North Carolina, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, United States

  • Children'S Hospital of Virginia of Virginia Commonwealth University

    Richmond, Virginia, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jun 2018
Primary completion
23 Feb 2021
Completion
19 Aug 2021
Last update posted
9 Mar 2023
Registered enrollment
121
Registry id
NCT03439670

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.